Key Takeaways
- S&P 500 futures jumped 0.4% to session highs following reports that Iran submitted a new peace proposal to the U.S. via Pakistani mediators to end the current conflict.
- Crude oil prices (Brent and WTI) retreated sharply, leading to a recovery in U.S. Treasuries as energy-driven inflation fears showed signs of temporary abatement.
- Federal Reserve officials signaled a hawkish turn, with Minneapolis Fed President Neel Kashkari warning of potential rate hikes if the Strait of Hormuz remains closed and inflation expectations unanchor.
- Novo Nordisk (NVO) received FDA approval for the first oral GLP-1 (Ozempic pills) to reduce cardiovascular risks in Type 2 diabetes patients, with a U.S. launch set for May 4.
- Ukraine reported a massive drone barrage, with 409 Russian drones fired on Friday, prompting President Zelenskiy to announce a major military reform and special infantry contracts.
Geopolitical Breakthrough Sparks Market Relief
Global markets reacted positively on Friday to news that Iran has delivered a fresh proposal to the U.S. through Pakistani mediators. The proposal, aimed at ending the ongoing war, led to an immediate 0.4% surge in S&P 500 E-mini futures, while Dow futures rose 0.45% and Nasdaq 100 futures edged up 0.09%.
The diplomatic shift has already impacted energy logistics, with reports indicating an increasing number of oil tankers are being redirected back to Iran with their crude cargo. Investors are closely watching the potential reopening of the Strait of Hormuz, which has been a primary driver of recent energy price volatility and global supply chain disruptions.
Fed Officials Dissent on Easing Bias
Despite the positive geopolitical news, Federal Reserve officials are maintaining a cautious stance on monetary policy. Minneapolis Fed President Neel Kashkari warned that a prolonged closure of the Strait of Hormuz could force the Fed to implement a series of rate increases to defend its 2% inflation target.
Fed Governor Beth Hammack officially dissented against maintaining an "easing bias" in the central bank's latest statement. Hammack argued that a "clear easing bias" is no longer appropriate given that inflation pressures remain broad-based and the economic outlook for 2026 remains highly uncertain.
Healthcare and Tech Developments
In the pharmaceutical sector, Novo Nordisk (NVO) achieved a significant regulatory milestone. The FDA approved Ozempic tablets, the first oral peptide GLP-1 drug designed to reduce cardiovascular risks in adults with Type 2 diabetes. The company plans to launch the product in the U.S. market on May 4, potentially disrupting the injectable-dominated weight loss and diabetes landscape.
In technology and trade, Chinese startups are reportedly pivoting toward local incorporations following strict positions from regulators regarding overseas IPOs. Meanwhile, the Pentagon's tech division confirmed that while Anthropic remains blacklisted, the department is viewing Mythos as a separate matter for potential defense applications.
Global Security and Natural Disasters
The conflict in Eastern Europe continues to escalate as Ukraine's Air Force reported that Russia launched 409 drones within a seven-hour window on Friday. In response, President Volodymyr Zelenskiy announced the beginning of a comprehensive military reform, which includes the launch of special contracts for infantry to bolster national defense.
Adding to global instability, a 5.6 magnitude earthquake struck the Taiwan region on Friday, according to the GFZ German Research Centre for Geosciences. While immediate damage reports are pending, markets remain sensitive to any disruptions in the critical semiconductor supply chain located in the region.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.